Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children - Takeaways - MDSpire

Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children

  • By

  • Gabriella Ess

  • Christina A Rostad

  • January 10, 2025

  • 0 min

Share

  • 1

    RSV causes approximately 33 million acute lower respiratory infections and 3.6 million hospitalizations in children annually.

  • 2

    Nirsevimab and Abrysvo are new products for RSV prevention, but high costs and limited access hinder uptake.

  • 3

    The CPS-Ped score is an ordinal severity score developed to assess clinical improvement in infants hospitalized for RSV.

  • 4

    The study found that 65% of infants showed clinical improvement by day 7, with certain factors affecting recovery.

  • 5

    CPS-Ped could standardize outcome metrics for RSV clinical trials, capturing clinical progression and healthcare utilization.

Original Source(s)

Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children

  • by Gabriella Ess, Christina A Rostad

  • January 10, 2025

Related Content

Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

Disseminated cystic echinococcosis presenting as orbital swelling in a child — case report and literature review